Anticancer activity, toxicity and pharmacokinetic profile of an indanone derivative

被引:45
作者
Chanda, Debabrata [1 ]
Bhushan, Shashi [2 ]
Guru, Santosh K. [2 ]
Shanker, Karuna [1 ]
Wani, Z. A. [2 ]
Rah, B. A. [2 ]
Luqman, Suaib [1 ]
Mondhe, Dilip M. [2 ]
Pal, Anirban [1 ]
Negi, Arvind S. [1 ]
机构
[1] Cent Inst Med & Aromat Plants CSIR CIMAP, Lucknow 226015, Uttar Pradesh, India
[2] Indian Inst Integrat Med CSIR IIIM, Canc Pharmacol Div, Jammu 180001, India
关键词
Gallic acid; Indanone; In vivo anticancer activity; Tubulin polymerisation inhibition; Acute oral toxicity; Pharmacokinetics; SAFETY EVALUATION; NATURAL-PRODUCTS; VEGF EXPRESSION; CANCER; APOPTOSIS; AGENTS; CELLS; PATHWAYS; RATS;
D O I
10.1016/j.ejps.2012.08.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study describes anticancer effect of gallic acid based indanone derivative (1). Indanone 1 exhibited in vivo anticancer activity against Erhlich ascites carcinoma in Swiss albino mice by inhibiting tumor growth by 54.3% at 50 mg/kg b.wt. It showed antitubulin effect by inhibiting tubulin polymerase enzyme. In cell cycle analysis, it inhibited G2/M phase and induced apoptosis. It significantly suppressed VEGF-R1, VEGF-R2 and HIF-alpha in human breast cancer MCF-7 cells, thus exhibiting antiangiogenic activity. In acute oral toxicity, indanone 1 was well tolerated and was found to be non-toxic up to 1000 mg/kg b.wt. in Swiss albino mice. Pharmacokinetic studies in rabbits revealed rate of absorption, half life, volume of distribution with high plasma and blood clearance after iv. administration. Indanone 1, is a safe and moderately active anticancer agent. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:988 / 995
页数:8
相关论文
共 27 条
[1]   Safety evaluation of a standardized phytochemical composition extracted from Bacopa monnieri in Sprague-Dawley rats [J].
Allan, J. Joshua ;
Damodaran, A. ;
Deshmukh, N. S. ;
Goudar, K. S. ;
Amit, A. .
FOOD AND CHEMICAL TOXICOLOGY, 2007, 45 (10) :1928-1937
[2]  
[Anonymous], 2012, CANCER
[3]   A triterpenediol from Boswellia serrata induces apoptosis through both the intrinsic and extrinsic apoptotic pathways in human leukemia HL-60 cells [J].
Bhushan, Shashi ;
Kumar, Ajay ;
Malik, Fayaz ;
Andotra, Samar Singh ;
Sethi, Vijay Kumar ;
Kaur, Indu Pal ;
Taneja, Subhash Chandra ;
Qazi, Ghulam Nabi ;
Singh, Jaswant .
APOPTOSIS, 2007, 12 (10) :1911-1926
[4]   Safety evaluation of Trikatu, a generic Ayurvedic medicine in Charles Foster rats [J].
Chanda, Debabrata ;
Shanker, Karuna ;
Pal, Anirban ;
Luqman, Suaib ;
Bawankule, Dnyaneshwar Umrao ;
Mani, Dayanandan ;
Darokar, Mahendra Pandurang .
JOURNAL OF TOXICOLOGICAL SCIENCES, 2009, 34 (01) :99-108
[5]   Impact of Natural Products on Developing New Anti-Cancer Agents [J].
Cragg, Gordon M. ;
Grothaus, Paul G. ;
Newman, David J. .
CHEMICAL REVIEWS, 2009, 109 (07) :3012-3043
[6]   Binding of Indanocine to the Colchicine Site on Tubulin Promotes Fluorescence, and Its Binding Parameters Resemble Those of the Colchicine Analogue AC [J].
Das, Lalita ;
Gupta, Suvroma ;
Dasgupta, Dipak ;
Poddar, Asim ;
Janik, Mark E. ;
Bhattacharyya, Bhabatarak .
BIOCHEMISTRY, 2009, 48 (07) :1628-1635
[7]   Cancer mortality in India: a nationally representative survey [J].
Dikshit, Rajesh ;
Gupta, Prakash C. ;
Ramasundarahettige, Chinthanie ;
Gajalakshmi, Vendhan ;
Aleksandrowicz, Lukasz ;
Badwe, Rajendra ;
Kumar, Rajesh ;
Roy, Sandip ;
Suraweera, Wilson ;
Bray, Freddie ;
Mallath, Mohandas ;
Singh, Poonam K. ;
Sinha, Dhirendra N. ;
Shet, Arun S. ;
Gelband, Hellen ;
Jha, Prabhat .
LANCET, 2012, 379 (9828) :1807-1816
[8]   Lost in transcription: p21 repression, mechanisms, and consequences [J].
Gartel, AL ;
Radhakrishnan, SK .
CANCER RESEARCH, 2005, 65 (10) :3980-3985
[9]  
GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1
[10]  
Ghosh M.N., 1984, Fundamentals of Experimental Pharmacology